91
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Comparative study of pharmaceutical properties of some new derivatives of sulfamethoxazole

, &
Pages 613-618 | Received 08 May 2009, Accepted 06 Oct 2009, Published online: 06 Nov 2009

References

  • Brown AG, Roberts SM. Recent advances in the chemistry of β-lactum antibiotics. London: The Royal Society of Chemistry; 1984.
  • Ma M, Cheng Y, Xu Z, Xu P, Qu H, Fang Y, Xu T, Wen L. Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug. Eur J Med Chem 2007;42(1):93–98.
  • Brun-Pascaud M, Bertrand G, Chau F, Rajagopalan-Levasseur P, Garry L, Derouin F, Girard PM. Rat model of concurrent Pneumocystis carinii (Pc), Toxoplasma gondii (Tg), and Mycobacterium avium complex (MAC) infections for assessment of multiple prophylaxis. Antimicrob Agents Chemother 1998;42(5):1068–1072.
  • Sheela CD, Gomathi A, Ravichandran S, Tharmaraj P. Studies on Schiff base complexes of salicylaldehyde with sulphamethoxazole and their antimicrobial activities. Polish J Chem 2006;80:1781–1787.
  • Iqbal MS, Khan AH, Loothar BA, Bukhari IH. Effect of derivatization of sulfamethoxazole and trimethoprim with copper and zinc on their medicinal value. Med Chem Res 2009;18:31–42.
  • Yang XL, Liu J, Yang L, Zha X-Y. Synthesis, characterization, and susceptibility of bacteria of selenium dioxide complexes with sulfa drugs. Synth React Inorg Metal-Org Nano-Metal Chem 2005;35(10):761–766.
  • Iqbal MS, Bukhari IH, Arif M. Preparation, characterization and biological evaluation of copper(II) and zinc(II) complexes with Schiff bases derived from amoxicillin and cephalexin. Appl Organometal Chem 2005;19:864–869.
  • Baudry DB, Dormond A, Durisa F, Bernard JM, Desmurs JR. Lanthanide bis(trifluoromethanesulfonyl)amides, synthesis, characterization and catalytic activity. J Fluorine Chem 2003;121(2):233–238.
  • Okhamafe AO, Azubuike CPC. Direct compression studies on low-cost cellulose derived from maize cobs. J Pharm Biores 2004;1:26–29.
  • Audu-Peter JD, Ojile JE, Bhatia PG. Physiochemical and powder properties of alpha and microcrystalline-cellulose derived from maize cob. J Pharm Biores 2004;1:41–45.
  • Ohwoavworhua FO, Ogah EO, Kunle OO. Preliminary investigation of physicochemical and functional properties of alpha cellulose obtained from waste paper–a potential pharmaceutical excipient. J Raw Matr Res 2005;2:84–93.
  • Carr RL. Classifying flow properties of solids. Chem Eng 1965;72:69–72.
  • United States Pharmacopoeia. 30th ed; 2007.
  • Hausner HH. Friction conditions in a mass of metal powders. Int J Powder Metall 1967;3:7–13.
  • Krycer I, Pope DG, Hersey JA. An evaluation of the techniques employed to investigate powder compaction behavior. Int J Pharm 1982;12:113–134.
  • Heckel RW. An analysis of powder compaction phenomena. Trans Metallurg Soc AIME 1961;221:1001–1008.
  • Peleg M, Moreyra MR. Effect of moisture on the stress relaxation pattern of compacted powders. Powder Technol 1997;277–279.
  • Augsburger LL, Hoag SW, editors. Pharmaceutical dosage forms. Vol. 2. Rational design and formulation. 3rd ed. London: Informa; 2008:567.
  • Obiorah BA, Shotton E. The effects of waxes, hydrolyzed gelatin and moisture on the compression characteristics of paracetamol and phenacetin. J Pharm Pharmacol 1976;28:629–632.
  • Rees JE, Hersey. The strength of compacts containing moisture. Pharm Acta Helv 1972;47:235–243.
  • Augsburger LL, Hoag SW, editors. Pharmaceutical dosage forms. Vol. 2. Rational design and formulation. 3rd ed. London: Informa; 2008:73.
  • Augsburger LL, Hoag SW, editors, Pharmaceutical dosage forms. Vol. 2. Rational design and formulation. 3rd ed. Lodnon: Informa; 2008:562.
  • Martin A, Bustamante P, Chun AHC. Physical pharmacy. 4th ed. Baltimore, USA: Lippincott Williams and Wilkins; 2002;4:442–446.
  • Neumann BS. Advances in pharmaceutical sciences. Vol. 2. Bean SH, Careless JE, Beckett AH, editors. New York: Academic Press; 1967:181.
  • Pilpil N. Advances in pharmaceutical sciences. Vol. 3. Bean SH, Careless JE, Beckett AH, editors. New York: Academic Press; 1971:173–219.
  • Staniforth JN. Powder flow. In: Aulton ME, editor. Pharmaceutics – the science of dosage form design. 2nd ed. Spain: Churchill Livingston; 2002(2):205–207.
  • Paronen P, Lilla J. Porosity-pressure functions. In: Alderborn G, Nystron C, editors. Pharmaceutical powder compaction technology. New York: Marcel Dekker Inc; 1996:55–75.
  • Alderborn G, Nystron C. Pharmaceutical powder compaction technology. Vol. 71. In: Swarbrick J, editor. Drugs and pharmaceutical sciences. New York: Marcel Dekker Inc; 1996.
  • Podezek F, Revesz P. Evaluation of the properties of microcrystalline and microfine cellulose powders. Int J Pharm 1993;91:183–193.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.